COHEN NEIL HARRIS

PrivateCIK: 1840006
Location

CAMBRIDGE, MA

COHEN NEIL HARRIS (interim CEO) sold 19.4% of their position (2.41K shares) of CHEMOMAB THERAPEUTICS LTD. on the open market

Open‑market sale worth $4.8K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 1 sale
InsiderCOHEN NEIL HARRISCIK 1840006
DirectorOfficer· interim CEO
Since Apr 2020
+16.98K
Net shares
Net buyer
$4.8K
Total sold
1
Open market trades
0B · 1S
4
Total transactions
19.39K acquired · 2.41K disposed
Non-Derivative Transactions1

American Depositary Shares

Direct
S · Sale

Shares

2.41K

Price / share

$2.00

Trade value

$4.82K

% of position

19.4%
11/16/2022
12.41K10K
Total

Net shares

2.41K

Net value

-$4.82K

Derivative Transactions3

Option to Purchase American Depositary Shares

Direct
A · Award
Converts to

American Depositary Shares

688.00 shares

Shares

+688.00

Strike price

13.17

Held after

688.00

Exercisable

3/16/2021

Option to Purchase American Depositary Shares

Direct
A · Award
Converts to

American Depositary Shares

11.88K shares

Shares

+11.88K

Strike price

27.26

Held after

11.88K

Exercisable

4/19/2021

Option to Purchase American Depositary Shares

Direct
A · Award
Converts to

American Depositary Shares

6.82K shares

Shares

+6.82K

Strike price

3.53

Held after

6.82K

Exercisable

3/7/2022
COHEN NEIL HARRIS — Insider Transaction (Form 4) Filed Nov 18, 2022 | Finecho